webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

MC-Gly-Gly-Phe-Gly-PAB-PNP

  CAS No.: 2632342-16-4   Cat No.: BADC-01746 4.5  

MC-Gly-Gly-Phe-Gly-PAB-PNP is a peptide ADC linker intermediate containing cleavable sequences for enzyme-triggered drug release, supporting controlled payload delivery in antibody-drug conjugates. Keywords: ADC linker, peptide linker, enzyme-cleavable, payload release, controlled delivery.

MC-Gly-Gly-Phe-Gly-PAB-PNP

Structure of 2632342-16-4

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C39H41N7O12
Molecular Weight
799.78

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
[4-[[2-[[(2S)-2-[[2-[[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]phenyl]methyl (4-nitrophenyl) carbonate
Canonical SMILES
C1=CC=C(C=C1)CC(C(=O)NCC(=O)NC2=CC=C(C=C2)COC(=O)OC3=CC=C(C=C3)[N+](=O)[O-])NC(=O)CNC(=O)CNC(=O)CCCCCN4C(=O)C=CC4=O
InChI
InChI=1S/C39H41N7O12/c47-32(9-5-2-6-20-45-36(51)18-19-37(45)52)40-22-33(48)41-23-35(50)44-31(21-26-7-3-1-4-8-26)38(53)42-24-34(49)43-28-12-10-27(11-13-28)25-57-39(54)58-30-16-14-29(15-17-30)46(55)56/h1,3-4,7-8,10-19,31H,2,5-6,9,20-25H2,(H,40,47)(H,41,48)(H,42,53)(H,43,49)(H,44,50)/t31-/m0/s1
InChIKey
VZINFKOLHKBKRS-HKBQPEDESA-N

MC-Gly-Gly-Phe-Gly-PAB-PNP, a versatile synthetic peptide substrate utilized in biochemical and pharmacological research across various disciplines, stands as a cornerstone in numerous applications.

Enzyme Activity Assays: Positioned at the forefront of enzyme research, MC-Gly-Gly-Phe-Gly-PAB-PNP assumes a crucial role in investigating protease activity, particularly those targeting glycine-phenylalanine sequences. Upon enzymatic cleavage, this substrate releases a detectable product or chromophore, enabling precise quantification of enzyme kinetics.

Drug Screening: Within the sphere of pharmacology, MC-Gly-Gly-Phe-Gly-PAB-PNP emerges as a pivotal component for high-throughput evaluation of drug candidates designed to modulate protease activities. By furnishing researchers with a consistent and reliable substrate, this peptide facilitates the assessment of novel compounds in influencing protease behavior. This platform plays a critical role in discovering and refining therapeutic modalities targeting abnormal protease function in diseases such as cancer and neurodegeneration.

Biochemical Pathway Analysis: Delving into the intricate realm of biochemical pathways, MC-Gly-Gly-Phe-Gly-PAB-PNP acts as a guiding light for investigating proteolytic mechanisms. By analyzing cleavage patterns of the substrate, scientists unlock vital insights into the functions of specific proteases and their interactions within complex biological environments. This knowledge forms the bedrock for unraveling cellular processes and developing strategies to manipulate metabolic and signaling pathways with precision.

Diagnostic Tool Development: In the domain of medical diagnostics, MC-Gly-Gly-Phe-Gly-PAB-PNP emerges as a cornerstone for creating diagnostic assays aimed at detecting altered protease activity in clinical specimens. These assays play a crucial role in diagnosing conditions characterized by abnormal protease behavior, such as certain cancers or inflammatory disorders. By monitoring substrate conversions in patient samples, clinicians extract valuable information essential for disease surveillance and prognosis assessment.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records:
Send Inquiry
Verification code
Inquiry Basket